Priavoid at AAIC 2017

The Priavoid spin off project has been presented at the Alzheimer’s Association International Conference 2017 in London (16th to 20th of July). We have been at the booth of the Jülich Research Center (Number 119).

Prof. Dr. Dieter Willbold presented the preclinical results of Priavoids AD drug candidate on the 17th of July at 4:15 pm (session O2-14, Preclinical): “Aβ Oligomer Eliminating D-Enantiomeric Peptides Enhance Cognition and Impede Neurodegeneration Even By Oral Application”